Powder: -20°C for 3 years
In solvent: -80°C for 6 months
CP-409092 is a partial GABAA receptor agonist. It has anti-anxiety activity.
Description | CP-409092 is a partial GABAA receptor agonist. It has anti-anxiety activity. |
Targets&IC50 | GABAA receptor |
In vivo | [14C]CP-409,092(P.O.; 100 mg/kg; ) treatment, the total recovery is 89.1%+ or -3.2% for male rats and 89.3%+ or -0.58% for female rats. The pharmacokinetics of CP-409,092 (P.O.; 4 and 15 mg/kg;single intravenous) treatment , are characterized by high clearance of 169+ or -18 mL/min/kg, a volume of distribution of 8.99+ or -1.46 L/kg, and an oral bioavailability of 2.9%+ or -3%. |
Molecular Weight | 297.35 |
Formula | C17H19N3O2 |
CAS No. | 194098-25-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 6 months
DMSO: 41.67 mg/mL (140.14 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.